Cyclerion Therapeutics, Inc.
CRYSTALLINE FORMS OF AN sGC STIMULATOR

Last updated:

Abstract:

The present disclosure relates to crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1- ,2-a]pyrazine, which are useful as a stimulator of soluble guanylate cyclase (sGC). The present disclosure also provides pharmaceutically acceptable compositions comprising the crystalline forms and methods of using said compositions in the treatment of various disorders.

Status:
Application
Type:

Utility

Filling date:

7 Mar 2019

Issue date:

22 Apr 2021